Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 Next >
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Biotech and Pharmaceuticals Berkshire Hathaway Inc Social issues
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Business Technology Politics
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Europe News Markets Business
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Health care industry Pharmaceuticals Health & Science
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Biotech and Pharmaceuticals Breaking News: Technology Biotechnology
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Health & Science Pharmaceuticals Eli Lilly and Co
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Health care industry Business Companies
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Health & Science Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Business Health care industry Companies
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Science Business News Biotechnology
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Biotech and Pharmaceuticals Science Novo Nordisk A/S
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biotechnology Biotech and Pharmaceuticals Eisai Co Ltd
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Roche Holding AG Business Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Pharmaceuticals Viking Therapeutics Inc Health & Science
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Biotechnology Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Merck & Co Inc Novo Nordisk A/S Johnson & Johnson
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Business Pharmaceuticals Markets
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Science Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Biotech and Pharmaceuticals Healthy Returns Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Breaking News: Business Business News Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Business News Business Investment Strategy
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Novo Nordisk A/S Eli Lilly and Co US: News
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Government and politics Stock indices and averages Streaming media technology
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Artificial intelligence Bitcoin NVIDIA Corp
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Investment strategy ETF Edge Mondelez International Inc
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Science Deutsche Bank AG Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Healthy Returns Technology Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.